Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

AZD-0328

Generic Name: AZD-0328

Drug Type: Small Molecule

Chemical Formula: C_₁₃H_₁₆N_₂O

CAS Number: 220099-91-2

Unique Ingredient Identifier: 2B218X5QIY

Overview

AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.

Background

AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

Phase 2

Withdrawn

Posted: 2021/03/22

Sponsor:King's College Londo...

ID:NCT04810104

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Phase 1

Completed

Posted: 2008/09/15

Sponsor:AstraZeneca

ID:NCT00752830

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

Phase 1

Completed

Posted: 2008/08/21

Sponsor:AstraZeneca

ID:NCT00738959

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

Phase 1

Completed

Posted: 2008/05/30

Sponsor:AstraZeneca

ID:NCT00687141

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Phase 2

Terminated

Posted: 2008/05/01

Sponsor:AstraZeneca

ID:NCT00669903

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy